Dimethylamine → HCID 13726356, compound
Reaction equation
Cl[CH2:2][CH:3]1[CH2:9][N:8]([CH:10]([CH3:12])[CH3:11])[C:7](=[O:13])[C:6]2[CH:14]=[CH:15][CH:16]=[CH:17][C:5]=2[N:4]1[CH3:18].[CH3:19][NH:20][CH3:21]>CO>[CH3:18][N:4]1[C:5]2[CH:17]=[CH:16][CH:15]=[CH:14][C:6]=2[C:7](=[O:13])[N:8]([CH:10]([CH3:12])[CH3:11])[CH2:9][CH:3]1[CH2:2][N:20]([CH3:21])[CH3:19]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 100 °C
Procedure
A mixture of 5.0 g (0.02 mole) of 2-chloromethyl-1,2,3,4-tetrahydro-1-methyl-4-(1-methylethyl)-5H-1,4-benzodiazepin-5-one, and 15.0 g (0.45 mole) of dimethylamine, and 200 ml of methanol were placed in a steel bomb and heated and stirred at 100° C. for 15 hr. After concentrating in vacuo, the residue partitioned between dilute sodium hydroxide solution and chloroform. The chloroform layer was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The residue crystallized in isopropyl ether and was recrystallized twice from the same. It weighed 29.0 g (68%), m.p. 93°-95° C.
Workup
- temperatureheated
- concentrationAfter concentrating in vacuo
- customthe residue partitioned between dilute sodium hydroxide solution and chloroform
- dry with materialThe chloroform layer was dried over anhydrous sodium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue crystallized in isopropyl ether
- customwas recrystallized twice from the same
Sources & evidence
- ORD record
- ord-6396f5642097492d859a0af2d58e0d9c
- Source dataset
- uspto-grants-1987_11
- Patent number
- US04705853
Reaction notes
Loading…